Fisher Scientific Company L.L.C.

Fisher Scientific Company L.L.C., operating through its Fisher Science Education division and doing business as Thermofisher Scientific, supplies laboratory equipment, analytical instruments, reagents, consumables, and scientific supplies to federal agencies as a prime contractor on a full-and-open basis. The company is a for-profit limited liability company and subsidiary of Thermo Electron Corporation, headquartered in Hanover Park, Illinois. With 4,927 total awards in the source data spanning four decades and a combined potential value of $31.9 million, Fisher Scientific maintains no set-aside certifications and competes across the commercial marketplace without categorical restrictions.

Fisher Scientific's federal footprint centers on scientific instrumentation and laboratory consumables. Representative prime awards include a $236,628 purchase order from the Defense Health Agency for pregnancy test kits (awarded July 2024, extended through July 2029); a $202,500 sole-source contract with the NIH Clinical Center for culture media and quality control organisms over a base year plus two twelve-month option periods (awarded March 2023); a $250,000 sole-source purchase order from the NIH Clinical Center for reagents and supplies for the Microbiology Service Sterility Testing Lab, base year plus three twelve-month options (awarded March 2023); and a $450,000 five-year Indefinite Delivery Contract with the USDA Food Safety and Inspection Service for disposable pipets (established March 2021, generating eleven delivery orders with $60 thousand combined potential value). Equipment acquisitions span ultra-low temperature freezers, PCR systems (QuantStudio 3, QuantStudio 5, QuantStudio 5DX, absolute Q models), NanoDrop spectrophotometers, centrifuges, incubators, microplate readers and washers, cell imaging systems, and water purification systems. Consumables include reagents, antibodies, labeling kits, biological media, pipettes, personal protective equipment, and specialized chemicals for analytical and clinical applications.

Customer concentration clusters heavily in civilian health and research agencies. The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh leads by far—167 awards carrying $4.6 million combined potential value (about 14% of total dollars)—reflecting sustained demand for laboratory instrumentation and supplies supporting disease surveillance, pathogen detection, and pandemic response. The Department of the Navy Bureau of Medicine and Surgery ranks second with 49 awards and $3.7 million combined potential value (12% of dollars), supporting military medical and biological research operations. The FDA, NIH agencies, USDA Agricultural Research Service field locations, and the Department of Veterans Affairs constitute the remaining top-tier customers. Top five customers by potential value account for 39% of combined potential across 158 distinct agencies served.

Fisher Scientific operates under multiple parent vehicles. A Blanket Purchase Agreement with the Indian Health Service (HHSI241200410142B) carries 58 task orders; two Indefinite Delivery Contracts generate 41 and 11 delivery orders respectively ($162 thousand and $60 thousand combined potential value); a Federal Supply Schedule (V797P5497X) supports 9 task orders; and a Blanket Purchase Agreement with the Department of Defense (W911QY11A0024) carries 9 task orders and $125 thousand combined potential value. These vehicles position Fisher Scientific for recurring supply relationships across civilian and defense laboratories.

Award activity has trended downward in recent years: 62 awards in 2022, 66 in 2023, 38 in 2024, 15 in 2025, and 8 in 2026 (through mid-September). Only two awards face ultimate completion in the next twenty-four months (combined potential value $22 thousand), indicating minimal recompete pressure near term; the majority of the portfolio consists of low-value, single-transaction purchase orders rather than large IDVs or task order vehicles approaching renewal.

Fisher Scientific operates almost exclusively as a prime contractor—4,923 of 4,927 awards (100%) are prime, with only four sub-awards on record. Sub-award work involves equipment provision: a $430 thousand funding modification to a Forma Steri-Cult CO2 incubator for an unnamed customer (February 2025), a Forma Series 3 water-jacketed CO2 incubator option year funding under an unnamed contract (March 2024), equipment procurement under Arcticom LLC's Consequence Management Support Center Services IDIQ supporting Army National Guard CBRNE missions (April 2024), and Portable High Throughput Integrated Laboratory Identification Systems (PHILIS) Platform Modernization components under Mriglobal (March 2026).

By product category, Fisher Scientific's award distribution reflects laboratory consumables dominance: 2,939 awards (60%) fall under PSC Laboratory Equipment and Supplies; 637 awards (13%) under Medical and Surgical Instruments and Supplies; 414 awards (8%) under In Vitro Diagnostic Substances and Test Kits; 300 awards (6%) under Hospital Furniture and Supplies; and 154 awards (3%) under Chemicals. NAICS concentration mirrors this: Other Professional Equipment and Supplies Merchant Wholesalers (396 awards), Analytical Laboratory Instrument Manufacturing (382), Medical and Hospital Equipment Merchant Wholesalers (182), Surgical Appliance and Supplies Manufacturing (133), and In-Vitro Diagnostic Substance Manufacturing (79).

Fisher Scientific's federal profile is characterized by high transaction velocity across a broad customer base—the typical award under $50 thousand—rather than large, long-term prime contracts. The company functions as a catalog supplier to federal laboratories, with purchases driven by agency consumables budgets and equipment refresh cycles rather than competitive task order competition against integrators or system contractors.